159 related articles for article (PubMed ID: 15857401)
1. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
2. Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
Mol Cell Neurosci; 2004 Mar; 25(3):355-62. PubMed ID: 15033164
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
[TBL] [Abstract][Full Text] [Related]
4. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.
Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J
Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648
[TBL] [Abstract][Full Text] [Related]
5. The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol.
Lee MC; Smith FL; Stevens DL; Welch SP
J Pharmacol Exp Ther; 2003 May; 305(2):593-9. PubMed ID: 12606657
[TBL] [Abstract][Full Text] [Related]
6. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
[TBL] [Abstract][Full Text] [Related]
7. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.
Cannich A; Wotjak CT; Kamprath K; Hermann H; Lutz B; Marsicano G
Learn Mem; 2004; 11(5):625-32. PubMed ID: 15466318
[TBL] [Abstract][Full Text] [Related]
8. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
9. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.
Oliva JM; Ortiz S; Palomo T; Manzanares J
J Psychopharmacol; 2004 Mar; 18(1):59-65. PubMed ID: 15107186
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
12. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
13. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
14. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
15. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
16. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
[TBL] [Abstract][Full Text] [Related]
17. Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors.
Bass CE; Welch SP; Martin BR
Eur J Pharmacol; 2004 Aug; 496(1-3):99-108. PubMed ID: 15288581
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims.
Hungund BL; Vinod KY; Kassir SA; Basavarajappa BS; Yalamanchili R; Cooper TB; Mann JJ; Arango V
Mol Psychiatry; 2004 Feb; 9(2):184-90. PubMed ID: 14966476
[TBL] [Abstract][Full Text] [Related]
19. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
